| Dec 31,
2014 | Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net earnings | 173 | 154 | 231 | 277 | 435 | 402 | 315 | 483 | 458 | 541 | 598 |
|---|
| Depreciation and amortization | 49 | 53 | 67 | 67 | 86 | 83 | 81 | 83 | 98 | 112 | 119 |
|---|
| Impairment of intangible assets | - | - | - | - | - | - | 102 | - | - | 8 | - |
|---|
| Loss on divestitures | - | -104 | -84 | - | - | - | - | - | -7 | - | - |
|---|
| Share-based compensation | 13 | 15 | 17 | 16 | 20 | 20 | 21 | 23 | 25 | 26 | 28 |
|---|
| Unrealized losses on investments, net | - | - | - | - | - | - | - | 26 | -0 | -1 | -1 |
|---|
| Deferred income taxes | - | -2 | 6 | 25 | 64 | 30 | 24 | 44 | 71 | 68 | 44 |
|---|
| Other items | 11 | -11 | -8 | 3 | -8 | -4 | -4 | 8 | 13 | -1 | -2 |
|---|
| Accounts and notes receivable | 8 | 14 | 20 | 23 | 9 | 6 | 2 | -32 | 53 | 12 | 7 |
|---|
| Inventories | -3 | 6 | 16 | 4 | 20 | -5 | 8 | 106 | 62 | -45 | -17 |
|---|
| Accounts payable | 43 | -15 | 3 | 0 | 34 | -11 | -2 | 40 | 3 | -34 | 4 |
|---|
| Other assets and liabilities | - | - | - | - | - | - | - | - | 43 | -17 | -38 |
|---|
| Net cash provided by operating activities | 256 | 257 | 378 | 347 | 458 | 488 | 490 | 489 | 460 | 601 | 675 |
|---|
| Capital expenditures | 52 | 35 | 43 | 49 | 49 | 66 | 47 | 45 | 64 | 84 | 92 |
|---|
| Acquisition of and equity investments in businesses, net of cash acquired | - | - | - | - | - | 8 | 13 | 7 | 923 | 32 | 137 |
|---|
| Proceeds from sale of equity method investment | - | - | - | 16 | - | - | - | 8 | - | - | - |
|---|
| Other investing activities, net | - | - | - | - | 5 | 8 | -6 | -13 | 7 | 13 | -1 |
|---|
| Net cash used in investing activities | -35 | -534 | -64 | -50 | -444 | -78 | -57 | -32 | -994 | -129 | -228 |
|---|
| Debt repayments | - | - | - | - | - | - | 0 | - | 13 | 13 | 413 |
|---|
| Proceeds from Lines of Credit | - | 400 | - | 165 | 115 | - | - | - | 340 | 30 | - |
|---|
| Repayments of Revolving Facility | - | - | - | - | 115 | - | - | - | 271 | 99 | - |
|---|
| Proceeds from issuance of Term Facility | - | - | - | 800 | - | 400 | - | 250 | - | - | - |
|---|
| Proceeds from issuance of Senior Notes | - | - | - | - | - | - | - | - | 600 | - | 400 |
|---|
| (Repayments of) proceeds from debt, net | -78 | 278 | -64 | 10 | -36 | -18 | -0 | 11 | 656 | -82 | -13 |
|---|
| Debt financing costs | 6 | 9 | 0 | 10 | - | 4 | - | 2 | 10 | - | 8 |
|---|
| Dividends paid to ordinary shareholders | 30 | 38 | 46 | 61 | 79 | 101 | 117 | 129 | 144 | 159 | 167 |
|---|
| Proceeds from Stock Options Exercised | - | - | - | - | - | - | - | - | - | - | 15 |
|---|
| Repurchase of ordinary shares | 50 | 30 | 85 | 60 | 67 | 226 | 209 | 413 | 61 | 60 | 220 |
|---|
| Other financing activities, net | 19 | -0 | -3 | -3 | -4 | - | -0 | 3 | -4 | 2 | -1 |
|---|
| Net cash (used in) provided by financing activities | - | - | - | - | - | -342 | -322 | -529 | 437 | -299 | -394 |
|---|
| Effect of exchange rate changes on cash and cash equivalents | - | - | - | - | -6 | -0 | 10 | -10 | -12 | 7 | -16 |
|---|
| Net increase (decrease) in cash and cash equivalents | - | - | - | - | -176 | 68 | 122 | -82 | -110 | 180 | 36 |
|---|